Moreover, our results establish human soluble FADD as a marker of joint inflammation during rheumatoid arthritis (RA) and gout attack, two inflammatory rheumatic diseases involving the NLRP3 inflammasome38–40. Here, NLRP3 is linked to rheumatoid arthritis.